PiLeJe has played a pioneering role in the study of probiotics, developing protocols for the investigation and selection of specific probiotic strains.
The PiLeJe laboratory pioneered the study of probiotics, and for many years has performed and published multiple experimental studies of probiotic strains, including their resistance to different physical and chemical conditions (for instance, their sustainability and resistance to different environments) and their impact on health. It thus contributes to the progress of scientific research in this area.
In 1990, it developed and marketed one of the first formulae in France to include probiotics.
Over many years, PiLeJe has developed protocols for investigating and selecting specific probiotic strains. Along with other processes, this work makes it possible to test the clinical efficacy of PiLeJe's increasingly sophisticated health solutions Fresh avenues for research are continually being discovered, opening up possibilities for the therapies of the future.
A microbiota is a set of micro-organisms (bacteria, yeasts, fungi and viruses) that lives in a particular environment. Formerly called “flora”, the microbiota is present in humans where the body is in contact with the external environment (nose, mouth, intestines, skin and vagina etc.)
Thus there is not just one but several microbiota. We talk of the nasal, buccal, intestinal, cutaneous and vaginal etc. microbiota.
The best known and the first to have been studied is the intestinal microbiota. Bacteria are the predominant type of micro-organism. Each person has his or her own intestinal microbiota, comprising around 150 - 200 different species of bacterium, representing approximately 10,000 billion bacteria, or 1 times more than the number of cells making up our bodies.
